While the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal cancers. For example, survival rates for myeloma, a bone marrow cancer, jumped from 32% to 62%, liver cancer from 7% to 22% and lung cancer from 15% to 28%.